(Q40358602)

19 September 2017

title

Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep (English)

1 reference

Rift Valley fever phlebovirus

19 September 2017

main subject

0 references

1 reference

1 reference

Baptiste Dungu

1

1 reference

19 September 2017

Ian Louw

2

1 reference

19 September 2017

Alison Lubisi

3

1 reference

19 September 2017

Pamela Hunter

4

1 reference

19 September 2017

Beate F von Teichman

5

1 reference

19 September 2017

Michele Bouloy

6

1 reference

19 September 2017

language of work or name

English

0 references

publication date

12 May 2010

1 reference

19 September 2017

1 reference

19 September 2017

volume

28

1 reference

19 September 2017

issue

29

1 reference

19 September 2017

page(s)

4581-4587

1 reference

Genetic Analysis of Viruses Associated with Emergence of Rift Valley Fever in Saudi Arabia and Yemen, 2000-01

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.085

Sequences and coding strategies of the S RNAs of Toscana and Rift Valley fever viruses compared to those of Punta Toro, Sicilian sandfly fever, and Uukuniemi viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.085

Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.085

Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.085

The S segment of rift valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.085

Persistent infection of mammalian cells by Rift Valley fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.085

Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.085

Adverse response of non-indigenous cattle of European breeds to live attenuated Smithburn Rift Valley fever vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.085

Abortion in vaccinated sheep and cattle after challenge with Rift Valley fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.085

Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.085

10.1016/J.VACCINE.2010.04.085

7 January 2021

Identifiers

DOI

1 reference

19 September 2017

1 reference